GB9810193D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB9810193D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 1998-05-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9810193.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GlaxoSmithKline Biologicals SA

Original Assignee

SmithKline Beecham Biologicals SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-12

Filing date

1998-05-12

Publication date

1998-07-08

1998-05-12 Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA

1998-05-12 Priority to GBGB9810193.4A priority Critical patent/GB9810193D0/en

1998-07-08 Publication of GB9810193D0 publication Critical patent/GB9810193D0/en

1999-05-10 Priority to AU42601/99A priority patent/AU4260199A/en

1999-05-10 Priority to EP99950345A priority patent/EP1086127A1/en

1999-05-10 Priority to PCT/EP1999/003262 priority patent/WO1999058562A2/en

1999-05-10 Priority to CA002328061A priority patent/CA2328061A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GBGB9810193.4A 1998-05-12 1998-05-12 Novel compounds Ceased GB9810193D0 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
GBGB9810193.4A GB9810193D0 (en)	1998-05-12	1998-05-12	Novel compounds
AU42601/99A AU4260199A (en)	1998-05-12	1999-05-10	Novel compounds
EP99950345A EP1086127A1 (en)	1998-05-12	1999-05-10	Novel compounds
PCT/EP1999/003262 WO1999058562A2 (en)	1998-05-12	1999-05-10	Novel compounds
CA002328061A CA2328061A1 (en)	1998-05-12	1999-05-10	Novel compounds

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9810193.4A GB9810193D0 (en)	1998-05-12	1998-05-12	Novel compounds

Publications (1)

Publication Number	Publication Date
GB9810193D0 true GB9810193D0 (en)	1998-07-08

Family

ID=10831938

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9810193.4A Ceased GB9810193D0 (en)	1998-05-12	1998-05-12	Novel compounds

Country Status (5)

Country	Link
EP (1)	EP1086127A1 (en)
AU (1)	AU4260199A (en)
CA (1)	CA2328061A1 (en)
GB (1)	GB9810193D0 (en)
WO (1)	WO1999058562A2 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008504292A (en)	2004-06-24	2008-02-14	ノバルティスヴァクシンズアンドダイアグノスティクス，インコーポレイテッド	Immune enhancement compounds
US20110104186A1 (en)	2004-06-24	2011-05-05	Nicholas Valiante	Small molecule immunopotentiators and assays for their detection
EP2357000A1 (en)	2005-10-18	2011-08-17	Novartis Vaccines and Diagnostics, Inc.	Mucosal and systemic immunizations with alphavirus replicon particles
CA2630220C (en)	2005-11-22	2020-10-13	Doris Coit	Norovirus and sapovirus antigens
EP1998800A2 (en)	2006-01-18	2008-12-10	University Of Chicago	Compositions and methods related to staphylococcal bacterium proteins
ATE539079T1 (en)	2006-03-23	2012-01-15	Novartis Ag	IMIDAZOCHINOXALINE COMPOUNDS AS IMMUNE MODULATORS
GB0713880D0 (en)	2007-07-17	2007-08-29	Novartis Ag	Conjugate purification
JP5653215B2 (en)	2007-09-12	2015-01-14	ノバルティスアーゲー	GAS57 mutant antigen and GAS57 antibody
DK2235046T3 (en)	2007-12-21	2012-10-29	Novartis Ag	Mutant forms of streptolysin-O
PT2268618E (en)	2008-03-03	2015-10-12	Novartis Ag	Compounds and compositions as tlr activity modulators
CN102481349B (en)	2009-01-12	2014-10-15	诺华股份有限公司	Cna_B Domain in Vaccines Against Gram-Positive Bacteria
AU2010258677B2 (en)	2009-06-10	2016-10-06	Glaxosmithkline Biologicals S.A.	Benzonaphthyridine-containing vaccines
ES2596653T3 (en)	2009-06-16	2017-01-11	Glaxosmithkline Biologicals Sa	Opsonization bactericidal and antibody-dependent assays mediated by high-performance complement
JP5988492B2 (en)	2009-09-02	2016-09-07	ノバルティスアーゲー	Immunogenic composition comprising a TLR activity modulator
TWI445708B (en)	2009-09-02	2014-07-21	Irm Llc	Compounds and compositions as regulators of TLR activity
WO2011057148A1 (en)	2009-11-05	2011-05-12	Irm Llc	Compounds and compositions as tlr-7 activity modulators
WO2011084549A1 (en)	2009-12-15	2011-07-14	Novartis Ag	Homogeneous suspension of immunopotentiating compounds and uses thereof
EA031379B1 (en)	2010-03-23	2018-12-28	Новартис Аг	Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
KR20130121699A (en)	2010-05-28	2013-11-06	테트리스 온라인, 인코포레이티드	Interactive hybrid asynchronous computer game infrastructure
US9192661B2 (en)	2010-07-06	2015-11-24	Novartis Ag	Delivery of self-replicating RNA using biodegradable polymer particles
ES2670863T3 (en)	2013-02-01	2018-06-01	Glaxosmithkline Biologicals Sa	Intradermal administration of immunological compositions comprising Toll-like receptor agonists
US11458151B2 (en)	2018-02-12	2022-10-04	Inimmune Corporation	Toll-like receptor ligands
JP2023547677A (en)	2020-11-04	2023-11-13	エリゴ・バイオサイエンス	Cutibacterium acnes recombinant phage, its production method and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5712118A (en) *	1993-09-29	1998-01-27	Research Foundation Of State University Of New York	Vaccine for branhamella catarrhalis
US5607846A (en) *	1994-05-17	1997-03-04	Research Foundation Of State University Of New York	Vaccine for moraxella catarrhalis
US7341727B1 (en) *	1996-05-03	2008-03-11	Emergent Product Development Gaithersburg Inc.	M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
US6004562A (en) *	1996-08-16	1999-12-21	The Research Foundation Of The State University Of New York	Outer membrane protein B1 of Moraxella catarrhalis

1998
- 1998-05-12 GB GBGB9810193.4A patent/GB9810193D0/en not_active Ceased
1999
- 1999-05-10 AU AU42601/99A patent/AU4260199A/en not_active Abandoned
- 1999-05-10 EP EP99950345A patent/EP1086127A1/en not_active Withdrawn
- 1999-05-10 CA CA002328061A patent/CA2328061A1/en not_active Abandoned
- 1999-05-10 WO PCT/EP1999/003262 patent/WO1999058562A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO1999058562A3 (en)	2001-05-17
AU4260199A (en)	1999-11-29
EP1086127A1 (en)	2001-03-28
CA2328061A1 (en)	1999-11-18
WO1999058562A2 (en)	1999-11-18

Publication	Publication Date	Title
GB9803411D0 (en)	1998-04-15	Novel compounds
GB9801392D0 (en)	1998-03-18	Novel compounds
GB9810193D0 (en)	1998-07-08	Novel compounds
GB9803751D0 (en)	1998-04-15	Novel compounds
GB9802826D0 (en)	1998-04-08	Novel compounds
GB9800337D0 (en)	1998-03-04	Novel compounds
GB9802655D0 (en)	1998-04-01	Novel compounds
GB9802654D0 (en)	1999-03-24	Novel compounds
GB9802646D0 (en)	1998-04-01	Novel compounds
GB9802656D0 (en)	1998-04-01	Novel compounds
GB9802645D0 (en)	1998-04-01	Novel compounds
GB9802644D0 (en)	1998-04-01	Novel compounds
GB9802824D0 (en)	1998-04-08	Novel compounds
GB9802640D0 (en)	1998-04-01	Novel compounds
GB9802639D0 (en)	1998-04-01	Novel compounds
GB9802638D0 (en)	1998-04-01	Novel compounds
GB9802533D0 (en)	1998-04-01	Novel compounds
GB9802387D0 (en)	1998-04-01	Novel compounds
GB9801882D0 (en)	1998-03-25	Novel compounds
GB9801643D0 (en)	1998-03-25	Novel compounds
GB9819278D0 (en)	1998-10-28	Novel compounds
GB9803650D0 (en)	1998-04-15	Novel compounds
GB9803567D0 (en)	1998-04-15	Novel compounds
GB9803566D0 (en)	1998-04-15	Novel compounds
GB9803428D0 (en)	1998-04-15	Novel compounds

Legal Events

Date	Code	Title	Description
1999-08-11	AT	Applications terminated before publication under section 16(1)